Want to join the conversation?
Mike Otway with Wolfe Research asks about the front-end comp trajectory over the next couple of quarters. $WBA said the company has been in this transition period before and has seen nice improvements in the operating margin and GM within that. So the comps should gradually improve quarter by quarter.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?